Michael Hanley

Michael Hanley

Chief Operating Officer at ALTO NEUROSCIENCE, INC.

Net worth: - $ as of 30/06/2026

53 year
Health Technology
Consumer Services

Profile

Michael Conick Hanley currently works at Alto Neuroscience, Inc., as Chief Operating Officer from 2024.
Mr. Hanley also formerly worked at Spyre Therapeutics, Inc., as Chief Business Officer from 2022 to 2023, Horizon Therapeutics Ltd. (Ireland), as Group Vice President-Marketing from 2015 to 2017, and Esteve Pharmaceuticals SA, as Chief Commercial Officer-US & Vice President from 2018 to 2019.
Mr. Hanley received his undergraduate degree from Notre Dame University and Masters Business Admin degree from Kellogg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/03/2026 0 ( -.--% ) - $ 30/06/2026

Michael Hanley active positions

CompaniesPositionStart
ALTO NEUROSCIENCE, INC. Chief Operating Officer 20/05/2024

Former positions of Michael Hanley

CompaniesPositionEnd
SPYRE THERAPEUTICS, INC. Corporate Officer/Principal 14/04/2023
Corporate Officer/Principal 01/09/2019
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Corporate Officer/Principal -
See the detail of Michael Hanley's experience

Training of Michael Hanley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

14

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Hanley